Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,548.90
(
-0.17%
)
News Focus
News Focus
Post# of 20617
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Biotech Pharmer

Send PM Follow Ignore
Followers 0
Posts 1521
Boards Moderated 0
Alias Born 09/16/2005

Biotech Pharmer

Re: jtaylor68 post# 11035

Wednesday, 08/09/2017 2:53:46 PM

Wednesday, August 09, 2017 2:53:46 PM

Post# of 20617
Damaj should have negotiated in holding off on first shipment until Jan. with allergy season winding down. He was probably forced into this by Hikma because they know he is over a barrel and their other customers' Q3 and especially Q4 sales are winding down. Perfect deal for them. Not so much for INNV. It's just common sense...we're talking about an allergy drug
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today